Literature DB >> 28115362

Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype.

Smitha Sreedharan1, Naga Prathyusha Maturi1, Yuan Xie1, Anders Sundström1, Malin Jarvius2, Sylwia Libard1, Irina Alafuzoff1, Holger Weishaupt1, Mårten Fryknäs2, Rolf Larsson2, Fredrik J Swartling1, Lene Uhrbom3.   

Abstract

High-grade glioma (HGG) is a group of primary malignant brain tumors with dismal prognosis. Whereas adult HGG has been studied extensively, childhood HGG, a relatively rare disease, is less well-characterized. Here, we present two novel platelet-derived growth factor (PDGF)-driven mouse models of pediatric supratentorial HGG. Tumors developed from two different cells of origin reminiscent of neural stem cells (NSC) or oligodendrocyte precursor cells (OPC). Cross-species transcriptomics showed that both models are closely related to human pediatric HGG as compared with adult HGG. Furthermore, an NSC-like cell-of-origin enhanced tumor incidence, malignancy, and the ability of mouse glioma cells (GC) to be cultured under stem cell conditions as compared with an OPC-like cell. Functional analyses of cultured GC from these tumors showed that cells of NSC-like origin were more tumorigenic, had a higher rate of self-renewal and proliferation, and were more sensitive to a panel of cancer drugs compared with GC of a more differentiated origin. These two mouse models relevant to human pediatric supratentorial HGG propose an important role of the cell-of-origin for clinicopathologic features of this disease. Cancer Res; 77(3); 802-12. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 28115362     DOI: 10.1158/0008-5472.CAN-16-2482

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.

Authors:  Zhihong Chen; Cameron J Herting; James L Ross; Ben Gabanic; Montse Puigdelloses Vallcorba; Frank Szulzewsky; Megan L Wojciechowicz; Patrick J Cimino; Ravesanker Ezhilarasan; Erik P Sulman; Mingyao Ying; Avi Ma'ayan; Renee D Read; Dolores Hambardzumyan
Journal:  Glia       Date:  2020-07-08       Impact factor: 7.452

2.  Cellular origin of glioblastoma and its implication in precision therapy.

Authors:  Maojin Yao; Shu Li; Xiaojun Wu; Shuo Diao; Guoxin Zhang; Hua He; Liuguan Bian; Yicheng Lu
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

3.  Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approach.

Authors:  Ravinder Doneti; Akbar Pasha; Mahendran Botlagunta; S K Heena; Veera Venkata Vara Prasad Mutyala; Smita C Pawar
Journal:  Med Oncol       Date:  2022-09-01       Impact factor: 3.738

4.  Anatomic mapping of molecular subtypes in diffuse glioma.

Authors:  Qisheng Tang; Yuxi Lian; Jinhua Yu; Yuanyuan Wang; Zhifeng Shi; Liang Chen
Journal:  BMC Neurol       Date:  2017-09-15       Impact factor: 2.474

5.  Human cytomegalovirus immediate-early protein promotes survival of glioma cells through interacting and acetylating ATF5.

Authors:  Ming Hu; Bin Wang; Dongmeng Qian; Mengyuan Wang; Rui Huang; Li Wei; Ling Li; Li Zhang; David X Liu
Journal:  Oncotarget       Date:  2017-05-09

Review 6.  Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.

Authors:  Santiago Haase; Fernando M Nuñez; Jessica C Gauss; Sarah Thompson; Emily Brumley; Pedro Lowenstein; Maria G Castro
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 7.  T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges.

Authors:  Dalia Haydar; Jorge Ibañez-Vega; Giedre Krenciute
Journal:  Front Oncol       Date:  2021-10-25       Impact factor: 6.244

8.  Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival.

Authors:  Xi Lu; Naga Prathyusha Maturi; Malin Jarvius; Irem Yildirim; Yonglong Dang; Linxuan Zhao; Yuan Xie; E-Jean Tan; Pengwei Xing; Rolf Larsson; Mårten Fryknäs; Lene Uhrbom; Xingqi Chen
Journal:  Nat Commun       Date:  2022-04-25       Impact factor: 17.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.